Telefónica Ventures head of investments Pablo Moro tells Global Venturing Web3 and the metaverse are now among its priorities, with play-to-earn, tokenisation, VR and AR among the potential strategic areas.
Category: Firms
A resurgence in telecoms funds?
Telecoms investment funds had a boom in 2014-16 which has not been repeated since. But 2021 saw signs of an uptick with telcos in emerging markets creating investment funds.
What is strategic investing for a telecoms company in 2022?
As telecoms networks continue to expand their services, what even counts as a strategic investment these days? A selection of industry figures tell Global Venturing it can include Web3, ESG and 5G-related technologies.
Daily Deal Round Up: September 14, 2022
Pfizer Ventures has led a $102m series A for Capstan Therapeutics while Globis Capital Partners took part in an $85.4m round for Andpad.
Afya gets Gaspar to run corporate VC activities
Danilo Gaspar has been hired by the Brazilian medical education and digital health tool provider as head of corporate venture capital.
Daily Deal Round Up: September 13, 2022
Access Industries, Pfizer and SR One were among the investors in a $125m round for Nimbus Therapeutics while Aerwins agreed a reverse takeover.
Matsuoka moves away from Mistui & Co
Masaji Matsuoka has left Mistui & Co after more than 12 years and joined Magenta Venture Partners as managing general director.
Clouse closes BP stint to run EIC Rose Rock
David Clouse, a GCV Emerging Leader this year while at BP Ventures, will lead EIC Rose Rock, a $50m fund backed by Devon Energy, Onoek and Williams.
Experian Ventures’ Chehadé chooses new pastures
Senior investment director Karim Chehadé has announced his departure from Experian Ventures’ strategic investment vehicle, three months after colleague Chan Yip Pang.
Daily Deal Round Up: September 9, 2022
Hanwha Group took part in a $250m round for Carrot General Insurance while JP Morgan Chase helped lift LetsGetChecked’s series D to $170m.
Mark Brooks moves to head FMC Ventures
The former investment manager of Syngenta Group Ventures plans to expand the CVC arm of FMC Corporation, a US agriculture company.
Daily Deal Round Up: September 8, 2022
Reliance Egypt participated in Trukker’s $100m series C round while Merck, Eli Lilly and Heritage Medical all backed Photys’ $75m series A.
Daily Deal Round Up: September 7, 2022
SoftBank, Bristol Myers Squibb and Hitachi were among Arsenal Biosciences’ $220m round while MegaChips led a $140m round for Morse Micro.
Kortex Ventures: three-LP fund lets us give startups an honest proposition
With three health corporate LPs in tow, Kortex Ventures’ focus is digital and personalised.